PL1899334T3 - Związki naftyrydynowe - Google Patents
Związki naftyrydynoweInfo
- Publication number
- PL1899334T3 PL1899334T3 PL06773519T PL06773519T PL1899334T3 PL 1899334 T3 PL1899334 T3 PL 1899334T3 PL 06773519 T PL06773519 T PL 06773519T PL 06773519 T PL06773519 T PL 06773519T PL 1899334 T3 PL1899334 T3 PL 1899334T3
- Authority
- PL
- Poland
- Prior art keywords
- sub
- naphthyridine compounds
- histamine
- receptor
- serotonin
- Prior art date
Links
- 150000005054 naphthyridines Chemical class 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 4
- 229960001340 histamine Drugs 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 102000019208 Serotonin Plasma Membrane Transport Proteins Human genes 0.000 abstract 1
- 108010012996 Serotonin Plasma Membrane Transport Proteins Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69200305P | 2005-06-17 | 2005-06-17 | |
| PCT/US2006/023788 WO2006138714A2 (en) | 2005-06-17 | 2006-06-16 | Naphthyridine compounds |
| EP06773519A EP1899334B1 (en) | 2005-06-17 | 2006-06-16 | Naphthyridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1899334T3 true PL1899334T3 (pl) | 2009-04-30 |
Family
ID=37263777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06773519T PL1899334T3 (pl) | 2005-06-17 | 2006-06-16 | Związki naftyrydynowe |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7417054B2 (pl) |
| EP (1) | EP1899334B1 (pl) |
| JP (1) | JP2008543880A (pl) |
| CN (1) | CN101243083A (pl) |
| AT (1) | ATE409188T1 (pl) |
| AU (1) | AU2006261162A1 (pl) |
| CA (1) | CA2612409A1 (pl) |
| DE (1) | DE602006002894D1 (pl) |
| DK (1) | DK1899334T3 (pl) |
| ES (1) | ES2314933T3 (pl) |
| PL (1) | PL1899334T3 (pl) |
| PT (1) | PT1899334E (pl) |
| SI (1) | SI1899334T1 (pl) |
| WO (1) | WO2006138714A2 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030078347A1 (en) * | 2001-08-28 | 2003-04-24 | General Electric Company | Triazine compounds, polymers comprising triazine structural units, and method |
| SI1668014T1 (sl) * | 2003-09-17 | 2009-06-30 | Janssen Pharmaceutica Nv | Kondenzirane heterociklične spojine kot modulatorji serotoninskih receptorjev |
| CA2612495A1 (en) * | 2005-06-17 | 2006-12-28 | Janssen Pharmaceutica N.V. | Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| US7598255B2 (en) * | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| WO2008002817A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Butyl and butynyl benzyl amine compounds |
| JP2009542708A (ja) * | 2006-06-29 | 2009-12-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 置換アミノメチルベンズアミド化合物 |
| CA2656089A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Substituted benzyl amine compounds |
| FR2903904A1 (fr) * | 2006-07-21 | 2008-01-25 | Bioprojet Soc Civ Ile | Association de modafinil et d'un antagoniste ou agoniste inverse du recepteur h3 |
| TW200823204A (en) * | 2006-10-17 | 2008-06-01 | Arena Pharm Inc | Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto |
| WO2008064036A1 (en) * | 2006-11-16 | 2008-05-29 | Janssen Pharmaceutica N.V. | Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| RU2009136330A (ru) | 2007-03-01 | 2011-04-10 | Янссен Фармацевтика Н.В. (Be) | Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора |
| WO2008144305A1 (en) | 2007-05-18 | 2008-11-27 | Janssen Pharmaceutica N.V. | Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators |
| CN102046624A (zh) * | 2008-03-31 | 2011-05-04 | 埃沃特克股份有限公司 | 作为组胺h3受体拮抗剂的四氢萘啶及其氮杂衍生物 |
| JP5364327B2 (ja) * | 2008-09-26 | 2013-12-11 | 富士フイルム株式会社 | ハロピラジンカルボキサミド化合物の製造方法 |
| WO2016089800A1 (en) * | 2014-12-02 | 2016-06-09 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
| CN113024456B (zh) * | 2021-02-23 | 2022-05-13 | 江苏先导药业有限公司 | 一种2-氯烟酸的制备方法 |
| WO2026030052A1 (en) | 2024-07-31 | 2026-02-05 | Fmc Corporation | Fungicidal substituted azoles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH538477A (de) * | 1970-01-06 | 1973-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Isochinolin-Derivaten |
| GB1504424A (en) | 1975-08-09 | 1978-03-22 | Beecham Group Ltd | Isoquinoline-derived aminoethers |
| GB1558043A (en) * | 1976-02-03 | 1979-12-19 | Onoda Cement Co Ltd | Metal squeeze out tube and method and apparatus for forming a powder layer on its surface |
| ATE247469T1 (de) * | 1995-06-07 | 2003-09-15 | Pfizer | Heterocyclische kondensierte pyrimidin-derivate |
| EP0978512A1 (en) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
| JP4907817B2 (ja) | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | ノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するための、４−フェニル置換テトラヒドロイソキノリン類およびその利用 |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| EP1831173B1 (en) * | 2004-12-17 | 2011-01-26 | Janssen Pharmaceutica NV | Tetrahydroisoquinoline compounds for treatment of cns disorders |
-
2006
- 2006-06-16 WO PCT/US2006/023788 patent/WO2006138714A2/en not_active Ceased
- 2006-06-16 CA CA002612409A patent/CA2612409A1/en not_active Abandoned
- 2006-06-16 DE DE602006002894T patent/DE602006002894D1/de not_active Expired - Fee Related
- 2006-06-16 PL PL06773519T patent/PL1899334T3/pl unknown
- 2006-06-16 EP EP06773519A patent/EP1899334B1/en not_active Not-in-force
- 2006-06-16 JP JP2008517211A patent/JP2008543880A/ja not_active Withdrawn
- 2006-06-16 CN CNA200680030064XA patent/CN101243083A/zh active Pending
- 2006-06-16 SI SI200630141T patent/SI1899334T1/sl unknown
- 2006-06-16 PT PT06773519T patent/PT1899334E/pt unknown
- 2006-06-16 US US11/424,751 patent/US7417054B2/en active Active
- 2006-06-16 ES ES06773519T patent/ES2314933T3/es active Active
- 2006-06-16 AT AT06773519T patent/ATE409188T1/de not_active IP Right Cessation
- 2006-06-16 AU AU2006261162A patent/AU2006261162A1/en not_active Abandoned
- 2006-06-16 DK DK06773519T patent/DK1899334T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2314933T3 (es) | 2009-03-16 |
| JP2008543880A (ja) | 2008-12-04 |
| AU2006261162A1 (en) | 2006-12-28 |
| EP1899334B1 (en) | 2008-09-24 |
| DE602006002894D1 (de) | 2008-11-06 |
| CA2612409A1 (en) | 2006-12-28 |
| CN101243083A (zh) | 2008-08-13 |
| SI1899334T1 (sl) | 2009-04-30 |
| WO2006138714A3 (en) | 2007-03-15 |
| PT1899334E (pt) | 2008-11-06 |
| US20060287292A1 (en) | 2006-12-21 |
| DK1899334T3 (da) | 2008-11-24 |
| EP1899334A2 (en) | 2008-03-19 |
| US7417054B2 (en) | 2008-08-26 |
| WO2006138714A2 (en) | 2006-12-28 |
| ATE409188T1 (de) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG146683A1 (en) | Fused heterocyclic compounds as serotonin receptor modulators | |
| PT1899334E (pt) | Compostos de naftiridina | |
| ZA200802010B (en) | Pyrimidine compounds as serotonin receptor modulators | |
| WO2008002820A3 (en) | Substituted benzyl amine compounds | |
| ATE407927T1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
| MY145305A (en) | Cyclopropyl amines as modulators of the histamine h3 receptor | |
| ATE496892T1 (de) | Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen | |
| CL2008001122A1 (es) | Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas. | |
| MX2009004516A (es) | Metodos y terapias de combinacion para tratar enfermedad de alzheimer. | |
| UA89734C2 (en) | ANTAGONISTS of muscarinic acetylcholine receptors | |
| CL2009000161A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol; composicion farmaceutica que los comprende; uso en el tratamiento de trastornos neurodegenerativos, cognitivos o psicoticos, enfermedad de alzheimer, entre otros; y un kit que contiene a los compuestos. | |
| CL2008003659A1 (es) | Compuestos derivados de 6-(4-bencilpiperazin-1-il)pirimidin-4-ona, moduladores de la enzima estearoil-coa-desaturasa 1; procedimiento de preparacion; composicin farmaceutica; y uso en el tratamiento y profilaxis de la obesidad. | |
| IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
| AU2003290059A8 (en) | Use of cd137 antagonists for the treatment of tumors | |
| GB0416508D0 (en) | Therapeutic agents | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| TW200510398A (en) | Novel compounds | |
| MXPA05013478A (es) | Combinaciones terapeuticas. | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| IL162154A0 (en) | Prostagandin composition for the treatment of erectile dysfunction | |
| WO2006116311A3 (en) | Opioid receptor agonist compounds and their use in treatment of pain | |
| EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
| GB0515025D0 (en) | Organic compounds | |
| TW200744607A (en) | Pyrimidine compounds as serotonin receptor modulators | |
| GB0508988D0 (en) | Organic compounds |